Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05961956 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis

StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 24, 2025 (before its estimated April 18, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Nov 2025 to Apr 18, 2026
    • Study completion date: Nov 15, 2025 to Apr 18, 2026
    • Collaborators shortened, about 6 words
    v7
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 10 to confirmed 5
    • Site details revised
    v6
  3. Re-verified, no change to tracked fieldsv5
  4. Start date changed from estimate of Nov 2023 to Oct 12, 2023v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Aug 2023 to Nov 2023
    • Site details revised
    v3
  6. Start date: Jul 2023 to Aug 2023v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Prospective, single arm, single-center clinical study to test NVDX3 in patients suffering from low grade one level degenerative lumbar (L1 - S1) spondylolisthesis. NVDX3 will be implanted during a single surgical intervention.
Trial Details
NCT Number NCT05961956
Lead Sponsor Novadip Biosciences
Conditions
(from sponsor)		 Degenerative Lumbar Spondylolisthesis
Enrollment 5 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov